Molecule Optimization via Fragment-based Generative Models

by   Ziqi Chen, et al.

In drug discovery, molecule optimization is an important step in order to modify drug candidates into better ones in terms of desired drug properties. With the recent advance of Artificial Intelligence, this traditionally in vitro process has been increasingly facilitated by in silico approaches. We present an innovative in silico approach to computationally optimizing molecules and formulate the problem as to generate optimized molecular graphs via deep generative models. Our generative models follow the key idea of fragment-based drug design, and optimize molecules by modifying their small fragments. Our models learn how to identify the to-be-optimized fragments and how to modify such fragments by learning from the difference of molecules that have good and bad properties. In optimizing a new molecule, our models apply the learned signals to decode optimized fragments at the predicted location of the fragments. We also construct multiple such models into a pipeline such that each of the models in the pipeline is able to optimize one fragment, and thus the entire pipeline is able to modify multiple fragments of molecule if needed. We compare our models with other state-of-the-art methods on benchmark datasets and demonstrate that our methods significantly outperform others with more than 80 more than 10


page 1

page 2

page 3

page 4


Benchmarking Deep Graph Generative Models for Optimizing New Drug Molecules for COVID-19

Design of new drug compounds with target properties is a key area of res...

Learning to design drug-like molecules in three-dimensional space using deep generative models

Recently, deep generative models for molecular graphs are gaining more a...

Equivariant 3D-Conditional Diffusion Models for Molecular Linker Design

Fragment-based drug discovery has been an effective paradigm in early-st...

Learning to Extend Molecular Scaffolds with Structural Motifs

Recent advancements in deep learning-based modeling of molecules promise...

Deep Denerative Models for Drug Design and Response

Designing new chemical compounds with desired pharmaceutical properties ...

Re-evaluating sample efficiency in de novo molecule generation

De novo molecule generation can suffer from data inefficiency; requiring...

MIMOSA: Multi-constraint Molecule Sampling for Molecule Optimization

Molecule optimization is a fundamental task for accelerating drug discov...

Please sign up or login with your details

Forgot password? Click here to reset